TQ-A3334 tablets

DRUG2 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Hepatitis BNon Small Cell Lung Cancer

Phase 1

A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects

CompletedNCT06160895

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Hepatitis B

Start: 2023-12-26End: 2024-08-19Updated: 2024-10-30

A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets

TerminatedNCT06507891

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Non Small Cell Lung Cancer

Start: 2020-07-06End: 2024-06-04Updated: 2024-07-18